Importance of self-management (fluid restriction) in pulmonary arterial hypertension with right heart failure

Importance of self-management (fluid restriction) in pulmonary arterial hypertension with right heart failure - Self-management (fluid restriction)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00029667

Enrollment

Registered

2022-07-18

Start date

2022-07-27

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I27.0 I27.28

Interventions

Group 1: Control group: standard treatment Group 2: Intervention group: education for fluid restriction

weight management, regular phone visits

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: confirmed pulmonary hypertension with mPAP >19 mmHg and PAWP <16 mmHg; WHO functionall class incuding IPAH, HPAH, APAH; no change in therapy for 6 weeks; increades fluid intake (<2l/d) and/or signs of fluid overload and/or multiple decompensations in the past

Exclusion criteria

Exclusion criteria: underaged patients; no confirmed pulmonary hypertension; WHO group II-V; LVEF <50%; pulmonary disease defined as FEV1 <50% and/or TLC <70%; pregnancy/nursing period; not suitable for other medical reasons

Design outcomes

Primary

Measure	Time frame
change of the right atrial area; change of the right ventricular area both parameters from baseline to 24 weeks	—

Secondary

Measure	Time frame
weight, oedema, cardiac biomarkers, quality of life, quantity of hospitalizations, clinical outcome, Compliance, subjective parameters Baseline to week 12 and week 24	—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Sep 11, 2026